Obstetrician-Gynecologists and Perinatal Infections: A Review of Studies of the Collaborative Ambulatory Research Network (2005–2009) by Leddy, Meaghan A. et al.
Hindawi Publishing Corporation
Infectious Diseases in Obstetrics and Gynecology
Volume 2010, Article ID 583950, 7 pages
doi:10.1155/2010/583950
Review Article
Obstetrician-GynecologistsandPerinatal Infections:
AReview of Studiesof the Collaborative Ambulatory Research
Network (2005–2009)
Meaghan A. Leddy,1,2 BernardGonik,3 andJaySchulkin1
1Research Department, American College of Obstetricians and Gynecologists, 409 12th Street, SW, Washington, DC 20024, USA
2Department of Psychology, American University, 4400 Massachusetts Avenue, NW, Washington, DC 20016, USA
3Department of Obstetrics and Gynecology, Wayne State University School of Medicine, 6071 W. Outer Drive,
Detroit, MI 48235, USA
Correspondence should be addressed to Meaghan A. Leddy, meg.a.leddy@gmail.com
Received 26 April 2010; Accepted 10 October 2010
Academic Editor: Gilbert Donders
Copyright © 2010 Meaghan A. Leddy et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Background. Maternal infection is associated with adverse pregnancy outcomes, and ob-gyns are in a unique position to help
prevent and treat infections. Methods. This paper summarizes studies completed by the Research Department of the American
College of Obstetricians and Gynecologists regarding perinatal infections that were published between 2005 and 2009. Results.
Obstetrician-gynecologists are routinely screening for hepatitis B and HIV, and many counsel prenatal patients regarding hepatitis
B and toxoplasmosis. However, other infections are not regularly discussed, and many cited time constraints as a barrier to
counseling. A majority discusses the transmission of giardiasis and toxoplasmosis, but few knew the source of cryptosporidiosis or
cyclosporiasis.Conclusions.Manyoftherespondingob-gynswereunawareofornotadheringtoinfectionmanagementguidelines.
Obstetrician-gynecologists are knowledgeable regarding perinatal infections; however, guidelines must be better disseminated
perhaps via a single infection management summary. This paper identiﬁed knowledge gaps and areas in which practice can be
improved and importantly highlights the need for a comprehensive set of management guidelines for a host of infections, so that
physicians can have an easy resource when encountering perinatal infections.
1.Introduction
Pregnant women and their fetuses are at increased risk of
complications of viral, bacterial, and parasitic infections.
Maternal infection is associated with birth defects as well
as adverse pregnancy outcomes, such as intrauterine growth
restriction and preterm birth [1] and developmental disabil-
ities [2–4]. For example, cytomegalovirus (CMV) infection
can lead to hearing and/or vision loss, as well as cognitive
impairment in oﬀspring [5], and human immunodeﬁciency
virus(HIV)canresultininfectionandillnessinthenewborn
[6].
For most infections, eﬀective preventive strategies are
available; however, many pregnant women are not aware of
the threat of infection nor are they practicing preventive
strategies [7–9]. As such, obstetrician-gynecologists should
be knowledgeable about these risks and their prevention,
andshouldprovidepatientswithpreconceptionandprenatal
c o u n s e l i n g ,a sw e l la so ﬀering appropriate testing, vaccina-
tion and treatment.
The American College of Obstetricians and Gynecol-
ogists (ACOG) has investigated its physicians’ knowledge
of perinatal infections, including ACOG and Centers for
Disease Control and Prevention (CDC) guidelines, and
how they are counseling and managing their pregnant
patients. This paper summarizes studies of the Collaborative
AmbulatoryResearchNetworkregardingbacterial,viral,and
parasitic infections published between 2005 and 2009.
2. Methods
2.1. Description of the Collaborative Ambulatory Research
Network. The Collaborative Ambulatory Research Network
(CARN) was created in 1990 to assist in evaluating2 Infectious Diseases in Obstetrics and Gynecology
obstetrician-gynecologists’ practices, knowledge, and atti-
tudes regarding a variety of clinical concerns, as well as
provide Fellows and Junior Fellows timely information
on contemporary practice patterns and elucidate areas in
which increased education is needed. This project’s aim
was to change the way that research was being performed;
a majority of information regarding medical practice was
based on hospital, as opposed to ambulatory, practice.
The members of CARN are ACOG Fellows and Junior
Fellows who have volunteered to participate in several
researchstudiesperyear.AsofMarch2009,therewereatotal
of 1,305 CARN members, 50.4% male and 49.6% female.
Male members have a mean year of birth of 1954.2 ± 9.8
and a median year of 1953. Female members have a mean
year of birth of 1962.5 ± 8.7 and a median year of 1964. In
lightofthisdiﬀerence,eachofthestudiesreportedcontrolled
for age and gender in analysis and compared these groups to
identify and report any diﬀerences in knowledge, attitudes,
or practice. The mean year of birth of the entire CARN
sample is 1958.3 ± 10.1 and the median year is 1959. CARN
members are representative of each of the 11 ACOG districts,
10 of which are geographic regions, and one which is made
up of the U.S. military.
For all studies, a computer-generated random sample
of nonnetwork Fellows and Junior Fellows is included
as a reference group, and both CARN and non-CARN
members are mailed surveys simultaneously. Because CARN
members typically have a higher response rate, a greater
number of non-CARN members are sampled, in order to
maximize the probability that the non-CARN group is rep-
resentative of all practicing ACOG Fellows. Any signiﬁcant
diﬀerences between CARN and non-CARN respondents are
reported.
2.2. General Description of the Survey Questionnaires. Each
survey study was approved by an Institutional Review Board
and accompanied by a cover letter detailing the purpose of
the research and indicating that the return of a completed
survey would serve as a consent to participate in the study.
All ACOG survey studies are designed with the pur-
pose of generating descriptive data regarding obstetrician-
gynecologists’ contemporary practice patterns, clinical expe-
riences, topical knowledge, beliefs and attitudes, medical
school/residency training, access to professional and patient
resources, and self-reported educational needs. Demo-
graphic questions are included in all surveys, asking respon-
dents’ age, year of graduation from medical school, gender,
type of practice, racial distribution of patients, and location
of practice. Questionnaires have included many types of
questions: forced-choice (respondents must select a single
answer from options oﬀered), multiple answer (respondents
may choose all answers that apply), relative (respondents
rank or rate a set of statements), quantitative (respondents
must volunteer a number, e.g., percent of patients or number
of cases within a speciﬁed time period), or open-ended (e.g.,
describing an aspect of their typical course of treatment).
Sometimes scales (e.g., to examine respondents’ knowledge
or attitudes) are included in the survey. In those cases, a
Likert-type scale is used for a set of questions. The answers
to those questions can be combined to create a score to
investigate more global questions.
For the current review, all ACOG studies of obstetrician-
gynecologists’ knowledge, attitudes and/or practice regard-
ing perinatal infections that were conducted since 2005 were
included. Each study had a response rate of over 50%, with
respondents from each ACOG district, and thus, ﬁndings are
considered to be representative of nationwide practice.
3. Results
Obstetrician-gynecologists can counsel patients on how
to prevent infection and can also treat and monitor
patients who have an infection. One study [10]i n v e s t i -
gated obstetrician-gynecologists’ practices regarding infec-
tions during pregnancy in order to determine the range of
infections that are assessed during prenatal care. Ross and
colleagues [10] found that 88% of ob-gyns reported testing
all pregnant patients for hepatitis B virus. Only 1% reported
testing all patients for CMV infection, though 60% tested
upon patient request, 60% did so after patient reports of
signiﬁcant exposure, and 44% tested for CMV infection if a
fetal anomaly was identiﬁed; a similar practice pattern was
shown for parvovirus B19 infection [10]. Routine testing
for inﬂuenza is not recommended, and as such, few (4%)
physicians routinely test all patients for inﬂuenza. Most
commonly, physicians (40%) test for inﬂuenza virus after
p a t i e n tr e p o r to fe x p o s u r e[ 10]. Of note, these data were
collected prior to the recent novel H1N1 concerns in the
United States. Bordetella pertussis is also most commonly
tested for after patients report exposure (47%). There are
no professional guidelines for lymphocytic choriomeningitis
virus(LCMV)screening;however,30%reportedtestingafter
report of exposure, 14.8% upon patient request, and 14.4%
in cases of fetal anomaly [10].
A majority (67%) agreed that informing pregnant
patients about infection risk during pregnancy is a priority
in their practice [10]. Though many counsel patients on
preventingtoxoplasmosis(87.7%),hepatitisBvirus(78.8%),
and varicella-zoster virus (60%), less than half reported
counseling patients on preventing CMV, LCMV, and Borde-
tella pertussis infections. The majority reported counseling
typically occurred at initial prenatal exams [10].
Physicians are generally knowledgeable of the infections
thatcanresultinadverseoutcomesforwomenand/orfetuses
and are informed about the behavioral changes that can
reducetheriskofinfectionanddiscussedthemwithpatients,
though some were addressed more commonly than others
(seeTable 1)[10].However,despitethefactthatobstetrician-
gynecologists are knowledgeable of preventive measures, the
frequency with which these changes were recommended was
lower (see Table 1), with time constraints being a common
barrier to counseling [10]. Nearly all (96%) agreed that
prepared materials on infections would make counseling
easier [10].
The study by Ross and colleagues [10] demonstrated that
physicianscoverawidebreadthoftopicsrelatedtoinfections
during pregnancy, are knowledgeable of the consequences of
diverse infections, as well as means by which they can beInfectious Diseases in Obstetrics and Gynecology 3
Table 1: Percentage of CARN respondents who reported knowing
that various behaviors can prevent infection, and of those who
reported knowledge of the preventive behavior the percent who
reported recommending the behavior to reduce the risk of infection
during pregnancy.
Infection Prevention
Behavior
Knowledgeable
that behavior
prevents
infections (n)
Of those
knowledgeable of
preventive behavior,
the percent who
recommend behavior
to patients (n)
Avoiding cleaning cat
litter boxes 98.1% (262) 97.7% (257)
Cooking meat until
well done 92.0% (262) 82.2% (241)
Getting tested for HIV 91.6% (262) 97.1% (240)
Avoiding contact with
people who have
chickenpox or pertussis
90.8% (262) 87.0% (230)
Keeping up-to-date on
vaccines 89.7% (262) 89.4% (235)
Hand washing after
diaper changing 89.7% (262) 64.7% (235)
Avoiding wild or pet
rodents 88.5% (262) 63.8% (232)
Not sharing utensils
with toddlers 58.8% (262) 40.9% (254)
Not getting children’s
saliva in eyes or mouth 55.0% (262) 20.8% (144)
prevented. However, the study also revealed that due to time
constraints, counseling patients regarding the prevention of
infection is often omitted from patient care.
3.1. Cytomegalovirus. Cytomegalovirus infection occurs in
approximately 1 in 150 live births [11]a n dc a nl e a dt o
hearing loss, vision loss, and cognitive impairment in about
1 in 750 children [5]. Again, preventive strategies exist to
minimize the transmission of this infection.
Like the study by Ross and colleagues [10] ,as t u d ys p e -
ciﬁc to CMV [2] revealed that though many physicians are
cognizant of behavior changes that reduce infection, fewer
are providing this information to patients. For example, 90%
of ob-gyns knew hand washing reduces CMV infection risk,
though fewer (60%) routinely recommended hand washing
to pregnant patients [2]. Similarly, about half identiﬁed not
sharing utensils (57%) and avoiding children’s saliva (55%)
as reducing risk, though fewer recommend these behaviors
(31% and 30%, resp.).
Forty-four percent counsel patients about CMV preven-
tion, despite ACOG recommendations that pregnant women
be counseled about prevention methods [12]. However, in
accordance with ACOG’s statement that routine serologic
screening of all pregnant women for CMV is not recom-
mended, 99% reported they do not perform CMV testing on
all patients. Most provide testing after report of an exposure
(60.3%), when a fetal anomaly is identiﬁed (43.6%), or in
response to a patient request (31.8%). Just over one-quarter
(27%) reported having diagnosed it in a patient since 2003.
3.2. Group A Streptococcus. Group A Streptococcus (GAS) is
an uncommon, but serious cause of postpartum and post-
surgical infections. Despite the fact that GAS infections are
preventable [13], international estimates of GAS infections
have ranged from .33 to 3.16 per 1000 births in Jerusalem
[14] and were estimated as occurring 1 of every 11,000 live
births in the United Kingdom [15].
Van Beneden and colleagues [16] investigated post-
partum and postsurgical infections of Group A Strep-
tococcus (GAS). Obstetrician-gynecologists reported both
postpartum (3%) and postsurgical (7%) infections. Fewer
than one in ﬁve (14%) of ob-gyns reported routinely
obtaining diagnostic specimens for postpartum infections.
This may be due to the fact that physicians are aware
that infections are polymicrobial; over half responded that
the most common bacterial etiology of intrapartum (57%),
postpartum (62%), and postsurgical infections (52%) are
polymicrobial in nature. Additionally, many may avoid this
diagnostic approach due to the technical issue of obtaining
the specimen through a bacterially contaminated portal. Of
those who collected specimens, the microbial etiology was
determinedinonly28%ofthesamples.Inpostsurgicalcases,
microbiologic diagnoses were conﬁrmed in 20%. In 13% of
postpartum and 15% of postsurgical infections for which
diagnoses were conﬁrmed, GAS was found.
The majority (73%) of respondents reported that they
had not diagnosed any GAS infections. There are no ACOG
guidelines regarding GAS, and only 5.6% of respondents
stated that they were familiar with the 2002 CDC guidelines
for management of GAS infections, and more than 70%
were unaware of their existence. However, most (74%)
respondents stated that they do follow guidelines regarding
diagnosis, management, or treatment of postpartum and
postsurgical infections, primarily those put forth by ACOG
(59%) and those that are part of hospital infection control
protocols (32%) [16].
One important theme of the study by Van Beneden and
colleagues [16] was the ﬁnding that those who were older
and had more years in practice had diﬀerent practices than
those who were younger or with fewer years since residency.
T h o s ew h ow e r eo l d e rw e r em o r el i k e l yt om a k ea ne ﬀort to
determine the etiology of infections. This may be the result
of changing medical education and knowledge, or in the
epidemiology of these infections.
3.3. Human Immunodeﬁciency Virus. Human immunode-
ﬁciency virus (HIV) and the resulting acquired immune
deﬁciencysyndrome(AIDS)arepandemicandareassociated
with severe morbidity and mortality. In the United States,
women are reportedly the fastest-growing subgroup with
new HIV diagnoses [17]. Obstetrician-gynecologists are in
a unique position to provide HIV testing and one concern
relevant to obstetrician-gynecologists is the transmission of
HIV from mother to fetus. As such, numerous professional
organizations recommend that routine prenatal care include
HIV testing [17–20].4 Infectious Diseases in Obstetrics and Gynecology
Gray and colleagues [21] found that 97% of ob-gyns
adhere to ACOG guidelines [22] and recommend HIV
testing to all pregnant patients; ACOG recommends that
this be done as early in the pregnancy as possible and
with the opt-out method of screening where legally possible
[22]. Most (83.3%) of those who see pregnant patients
reported feeling at least moderately knowledgeable regarding
HIV in pregnancy, and 92% reported maintaining contact
with an infectious disease specialist for consultation [21].
Respondents most commonly (79%) reported that patients
refused HIV testing due to viewing themselves as low risk
[21]. When a patient declines testing, 28.7% do not reoﬀer
testing [21]. ACOG recommends that HIV testing should be
reoﬀered or repeated in the third trimester for women in
areas with high HIV prevalence, women known to be at high
risk for acquiring HIV infection, and women who declined
testing earlier in pregnancy [22].
Ifapatientarrivedatlaboranddeliverywithanunknown
or undocumented HIV status, 56.3% would act in accor-
dance with ACOG recommendations and conduct rapid
HIV testing, whereas 18.2% would not [22]. One quarter
(25.5%) stated rapid HIV testing at labor and delivery is
not available [21]. Testing strategies (opt-out versus opt-in
approaches) were not consistent with state regulations: 57%
use the approach required by their state, and 43% reported
using a method not approved by their state; 33% did not
know if their state had regulations requiring physicians to
recommend HIV testing during pregnancy [21].
Amor er ec entstudy[23]investigatedpatientperceptions
ofHIVtesting.Two-thirds(65%)ofpatientsreportedhaving
been tested for HIV at some point in the past, though 72%
did not recall if their current ob-gyn recommended testing
[23]. Among pregnant patients, 61% did not recall their
current provider having recommended testing, though 82%
had been tested at some point, with 71% receiving their test
results during the current pregnancy [23]. Young, pregnant,
Hispanic and African-American patients were most likely
to report that HIV testing had been recommended by
their obstetrician-gynecologist. Similar to the perceptions of
obstetrician-gynecologists [21], patients indicated they most
commonly decline testing because of seeing themselves as
low risk [23].
The results of these two studies indicate that physicians
must be made more familiar with state regulations regarding
HIV testing during pregnancy, and communication between
obstetrician-gynecologists and patients must be improved in
order to discuss HIV testing.
3.4. Listeriosis. If pregnant women have Listeriosis (Listeria
monocytogenes), they can develop severe bacteremia that
can spread to the meninges, lungs, liver, lymphatic system,
and placenta. Pregnant women are 20 times more likely
than healthy adults to contract this infection [24]. Perinatal
infection can lead to granulomatosis infantisepticum, a dis-
seminatedinfectionthatusuallyresultsinintrauterinedeath.
Neonatal listeriosis may present as early onset neonatal
sepsis in the ﬁrst week of life, or as late-onset meningitis
after the ﬁrst week, similar to the presentation of invasive
Group B streptococcal infection [25, 26]. Given these severe
risks, obstetricians are in a unique position to educate their
patients regarding this illness and its prevention, though
it should be mentioned there are currently no guidelines
regarding this illness.
In 2002, ACOG and the CDC collaborated to assess
a nationwide sample of pregnant women regarding their
knowledge of Listeriosis, and the Minnesota Department of
Healthconductedasimilarstudylimitedtopregnant women
within that state; the data were presented and compared
by Ogunmodede and colleagues [9]. A general lack of
knowledge about Listeriosis among pregnant women was
demonstrated. For example, less than 30% in both samples
knew that Listeriosis could be prevented by avoiding deli
meats, soft cheese (e.g., feta, brie), and unpasteurized dairy
products [9]. Less than 20% actually avoided delicatessen
and ready-to-eat foods while pregnant [9]. In fact, less than
20% had ever read, heard, or seen any information about
Listeriosis [9]. Listeriosis has signiﬁcant maternal and fetal
ramiﬁcations, and eﬀortsshould be made toeducate patients
about Listeriosis and its prevention.
3.5. Parasitic Disease. In addition to viral and bacterial infec-
tions, there are diverse food- and waterborne parasitic dis-
eases that can adversely aﬀect pregnant patients. One com-
prehensive study [27] focused on obstetrician-gynecologists’
practices and knowledge of eight food- and waterborne
parasitic diseases: toxoplasmosis, cryptosporidiosis, giardia-
sis, amebiasis, cyclosporiasis, trichinellosis, ascariasis, and
taeniasis.Respondentsweremostknowledgeableabouttoxo-
plasmosis; for example, 90.2% knew this illness causes severe
ocular and neurologic disease in the fetus, and 77% knew
a stool sample does not help diagnose toxoplasmosis [27].
However, only 28.2% correctly indicated that cryptosporid-
iosisismostlikelytobecontractedfromcontaminatedwater,
and only 19.3% identiﬁed that cyclosporiasis outbreaks have
been associated with raspberries [27].
Knowledge of treatment for parasitic illness was lack-
ing; only 10.1% correctly identiﬁed Paromomycin as the
safest medication to treat giardiasis in the ﬁrst trimester,
and only 28% knew that special laboratory testing is
needed to diﬀerentiate the pathogenic Entamoeba histolyt-
ica (the cause of amebiasis) from the nonpathogenic E.
dispar [27]. While 67.9% recognized that invasive ame-
biasis in nonpregnant patients should be treated with
metronidazole and then paromomycin, only 39.6% knew
that trimethoprim-sulfamethoxazole, metronidazole, and
amoxicillin were not the recommended treatment for cryp-
tosporidiosis in pregnant women [27].
3.6. Giardiasis. Giardiasis is a parasitic disease caused by the
protozoan Giardia intestinalis (Giardia lamblia)[ 28], and its
prevalence in industrialized countries ranges from 2% to
5% and upwards of 20% to 30% in developing countries
[29]. This parasitic disease can be especially problematic
for pregnant women; malabsorption and diarrhea can be
harmful to the fetus [30], but, at the same time, some
medications may have side eﬀects that aﬀect fetal develop-
ment [28]. Therefore, ob-gyns can play a role in identifying
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by Krueger et al. [31] found that a majority of ob-gyns
provided correct information regarding the transmission of
the diseases, prevention methods, and disease outcomes.
Response patterns indicate that physicians can beneﬁt
from further education regarding the treatment of giardiasis.
Under half (45.7%) correctly indicated that Tinidazole,
Metronidazole, and Nitazoxanide can all be used to treat
giardiasis, and 49.6% believed that only Metronidazole was
used to treat giardiasis [31]. Additionally, only 16.2% were
able to correctly identify that Paromomycin is the safest
drug treatment to use during the ﬁrst trimester [31]. Only
a third (33.2%) correctly indicated that it is not usually
recommended that asymptomatic carriers be treated [31].
Given the fact that ACOG has not published guidelines
regardingGiardiasisandtheresultsofthestudybyKruegeret
al.[31],itisimportantthatinformationregardingthisillness
be disseminated to clinicians.
3.7. Toxoplasmosis. Toxoplasma gondii, a protozoan parasite,
can infect humans through undercooked meats, ingestion
of contaminated water or soil, and cat or cat litter con-
tact [32–34]. Toxoplasmosis can cause neurological and
ocular damage to the fetus if a woman becomes newly
infected during pregnancy [35]. Though it is not particularly
common, it is important that physicians be cognizant of
the prevention, diagnostic, and treatment practices related
to toxoplasmosis. An ACOG Practice Bulletin states that
pregnant women should be counseled about methods to
prevent acquisition of toxoplasmosis during pregnancy [12].
About half (53.4%) of ob-gyns report counseling women
on prevention of toxoplasmosis at the initial prenatal visit,
and 3.3% reported never doing so [36]. Physicians reported
discussingthefollowingmeansoftransmissionwithpatients:
handlingcatlitter(99.6%),inadvertentcontactwithcatfeces
(98.0%), eating undercooked meat (77.6%), handling raw
meat (67.4%), gardening (65.4%), and washing fruits and
vegetables (34.2%) [36].
Most (73.2%) ob-gyns were unsure if there are problems
with commercial Toxoplasma IgM tests, despite reports of
high false-positive rates [37], but 68.8% reported they would
refer a patient with a positive test to a specialist. Almost all
(91.2%) had not heard of the avidity test, a test that can help
determine the timing of infection relative to pregnancy [36].
Ob-gyns should counsel patients about the risks of
toxoplasmosis and prevention methods. Additionally, they
should be aware of the avidity test, as well as the false-
positive rates of certain commercial IgM tests in order to
interpret them appropriately, and perhaps complete a second
test before moving on to more invasive procedures (e.g.,
amniocentesis).
4. Discussion
Common parasitic, viral, and bacterial infections are likely
to be encountered in regular obstetric and gynecologic
practice. Infections can have an impact on both mother
and fetus, and many are preventable either through avoid-
ing common transmission pathways, vaccination, or hand
washing. Obstetrician-gynecologists are in a unique position
to inform both pregnant women and mothers about the
spread of these illnesses, the potential consequences for
both mothers and babies, and prevention measures. Basic
knowledge of these diseases will improve physicians’ ability
toidentifyandtreatparasitic infections, whichwillminimize
the risks of harm to women and fetuses. This study is
important in that it reviews a half-decade of research on
the topic of infections in obstetric and gynecologic practice,
highlights improvements to be made, and suggests methods
by which guidelines can be better disseminated.
Results demonstrate that some infections (e.g., hepatitis
B) are screened for routinely by obstetrician-gynecologists.
In a similar vein, many counsel patients on a variety of
infections(e.g.,toxoplasmosis,hepatitisB),especiallyduring
prenatal exams, but there are some that are not regularly
discussed (e.g., CMV, LCMV, and Bordetella pertussis).
Physicians are also not commonly identifying the etiology of
intrapartum, postpartum, and postsurgical infections. While
this may be due to the likely polymicrobial nature of infec-
tions or that identiﬁcation of bacteria rarely changes ﬁrst-
line antibiotic treatment, pretreatment cultures facilitate
management of patients who fail initial empiric antibiotic
treatment [38]. Knowing the cause of an infection allows
for antimicrobial treatment to be appropriately tailored; this
is especially important when considering that the primary
causative infection agents change over generations. For
example, the principal etiology of early onset neonatal sepsis
has ranged from GAS in the 1930s–1940s, E. coli in the
1940s–1970s, to group B streptococci more recently [39].
Further, obtaining pretreatment cultures allows for speciﬁc
infection control measures to prevent the spread of disease.
Some improvement can be made in regards to physician
knowledge of certain illnesses; although a majority knew
and discussed the transmission of giardiasis [31]a n dt o x o -
plasmosis [36], only a minority knew that cryptosporidiosis
is a waterborne illness, and few knew that cyclosporiasis is
associated with raspberries [27]. Obstetrician-gynecologists
are knowledgeable of the adverse outcomes associated with
infections and are aware of preventive measures [2, 10, 27],
though, again, some were discussed more commonly than
others [2, 10]. Time constraints were commonly cited as
hindering one’s ability to counsel patients about prevention,
and it was indicated that prepared materials would facilitate
such discussions.
In order to assist physicians, many guidelines for
managing infections have been created; however, there is
some evidence that they are not being widely disseminated.
For example, almost three-quarters were unaware of the
existence of CDC guidelines for GAS infection management
[13], and only about half adhere to ACOG guidelines and
counsel patients about CMV (44%) [10] and toxoplasmosis
(53.4%) prevention [36]. Numerous professional organiza-
tions recommend that routine prenatal care should include
HIV testing [17–20], and obstetrician-gynecologists are
practicing accordingly [21]. However, testing strategies (opt-
out versus opt-in approaches) were not wholly consistent
with state regulations. In fact, 43% reported using a method
not approved by their state, and a third did not know if their
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HIV testing during pregnancy [21]. Similarly, only half of
respondents would act according to ACOG recommenda-
tions and conduct rapid HIV testing if a patient arrived at
labor and delivery with an unknown or undocumented HIV
status [22]; one quarter said this option was not available at
labor and delivery [21].
TherearesometopicsforwhichACOGhasnotpublished
guidelines (e.g., GAS, Giardiasis, Listeriosis), which may
result in the knowledge gaps demonstrated, particularly
for Giardiasis [31]. Guidelines on these topics can provide
physicians with information regarding best clinical practice,
which may increase discussion of such topics with patients,
as well as patients’ subsequent knowledge of infection
prevention which was shown to be weak (e.g., Listeriosis)
[9]. Further, it may be important for organizations like
ACOG or the CDC to create a comprehensive summary of
preventionandtreatmentguidelinesforphysicians,suchthat
theycanaccessasimplereferencereadilyandmakeinformed
decisions.
An additional tool that may minimize the time burden
and knowledge gaps and aid physicians in counseling
patientsregardinginfectionpreventionisthedevelopmentof
automated, computer-based, patient-centered, self counsel-
ing. These programs would allow for patients to learn about
infectiousdiseaseissuesontheirowntime,attheirownpace,
and become informed about prevention and consequences.
As with all research, this study has several limitations.
Firstly, all surveys were completed retrospectively, subjecting
them to possible recall bias. Physicians may be less accurate
in their estimates of how frequently they provide various
clinical services. Additionally, there is the possibility that
a social desirability eﬀect inﬂuenced physicians’ responses.
Participants may have selected responses they believed to
be socially acceptable or which presented them in a more
favorable light. For example, physicians may over-report
the frequency with which they counsel patients regarding
certain topics. Eﬀorts were made to minimize this eﬀect by
stressing conﬁdentiality and anonymity, as well as excluding
identifyinginformationfromthemeasures.Aﬁnallimitation
ofthisreviewisthatithasbeenlimitedonlytotopicscovered
by previous research; more common issues (e.g., group B
streptococcus,sexuallytransmittedinfections)havenotbeen
investigated, and so could not be reviewed here.
5. Conclusions
Obstetrician-gynecologists are knowledgeable regarding the
prevention, transmission, and management of a variety of
perinatal infections, though improvements can be made
regarding the information and counseling they provide to
patients. In particular, eﬀorts should be made to increase
the dissemination of guidelines for infection prevention and
management, as well as state regulations regarding HIV
testing in order to create uniform practice. Evidence-based
guidelines should be created for new areas, and physicians
s h o u l ds t r i v et ob ea w a r eo fr e c o m m e n d a t i o n sp u tf o r t hb y
other organizations; perhaps joint CDC-ACOG guidelines
would be of beneﬁt, especially if a single summary of
management guidelines was created. Additionally, eﬀorts
may be well guided to distribute prepared materials about
infectious diseases for patients, as obstetrician-gynecologists
reported that such materials would mitigate the impact of
time constraints.
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